Healthcare Economist August 22, 2024
Jason Shafrin

One key aspect of many medications is that they not only help people feel better, but often these medications can help them re-enter the workforce, work more hours, work more productively, or all of the above. However, when evaluating new treatments for diseases that impact older Medicare beneficiaries (≥65 years), should we take into account productivity impacts?

The first question to ask is, what share of individuals aged ≥65 years are actually in the labor force. Data form the Bureau of Labor Statistics (BLS) finds that 26.6% of individuals age 65-74 and 8.2% of individuals ≥75 years are in the labor force. Data from the Medicare Current Beneficiary Survey (MCBS) finds that “7.5 percent of beneficiaries were enrolled in Part...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Patient / Consumer, Provider
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes
RFK Jr. eyes overhaul of Medicare physician pay: What to know
CMS awards third round of Medicare-funded residency slots to hospitals

Share This Article